Formycon AG (ETR:FYB)
19.04
+0.04 (0.21%)
Aug 4, 2026, 5:35 PM CET
Formycon AG Revenue
In the year 2025, Formycon AG had annual revenue of 44.48M EUR, down -36.17%. Formycon AG had revenue of 24.98M in the quarter ending December 31, 2025, a decrease of -12.59%.
Revenue
44.48M
Revenue Growth
-36.17%
P/S Ratio
6.44
Revenue / Employee
257.52K
Employees
203
Market Cap
336.49M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.48M | -25.20M | -36.17% |
| Dec 31, 2024 | 69.67M | -8.02M | -10.32% |
| Dec 31, 2023 | 77.70M | 35.20M | 82.83% |
| Dec 31, 2022 | 42.50M | 5.88M | 16.07% |
| Dec 31, 2021 | 36.61M | 2.32M | 6.76% |
| Dec 31, 2020 | 34.30M | 1.14M | 3.43% |
| Dec 31, 2019 | 33.16M | -42.96B | -99.92% |
| Dec 31, 2018 | 42.99B | 42.96B | 148,135.43% |
| Dec 31, 2017 | 29.00M | 9.47M | 48.48% |
| Dec 31, 2016 | 19.53M | 2.61M | 15.41% |
| Dec 31, 2015 | 16.92M | 4.34M | 34.49% |
| Dec 31, 2014 | 12.59M | 12.31M | 4,456.93% |
| Dec 31, 2013 | 276.17K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.24B |
| Siemens Healthineers AG | 23.17B |
| Fresenius SE & Co. KGaA | 22.99B |
| Merck KGaA | 20.96B |
| Medios AG | 2.12B |
| MEDICLIN Aktiengesellschaft | 819.84M |
| Evotec SE | 745.04M |
| M1 Kliniken AG | 364.30M |
Formycon AG News
- 1 day ago - EQS-AFR: Formycon AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 21 days ago - EQS-News: Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars - Wallstreet:Online
- 7 weeks ago - EQS-News: Formycon AG Reports Results of Annual General Meeting 2026 - Wallstreet:Online
- 2 months ago - Formycon AG Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Formycon AG Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Formycon AG Earnings release: Q1 2026 - Filings
- 2 months ago - Formycon AG Slides: Q1 2026 - Filings
- 2 months ago - EQS-News: Formycon Reports Positive Operational Progress and Strong Revenue Growth in the First Quarter of 2026 - Wallstreet:Online